Lagatta, Joanne M.Hysinger, Erik B.Zaniletti, IsabellaWymore, Erica M.Vyas-Read, ShilpaYallapragada, SushmitaNelin, Leif D.Truog, William E.Padula, Michael A.Porta, Nicolas F. M.Savani, Rashmin C.Potoka, Karin P.Kawut, Steven M.DiGeronimo, RobertNatarajan, GirijaZhang, HuayanGrover, Theresa R.Engle, William A.Murthy, Karna2020-03-122020-03-122018-12Lagatta, J. M., Hysinger, E. B., Zaniletti, I., Wymore, E. M., Vyas-Read, S., Yallapragada, S., ... & Savani, R. C. (2018). The impact of pulmonary hypertension in preterm infants with severe bronchopulmonary dysplasia through 1 year. The Journal of pediatrics, 203, 218-224. 10.1016/j.jpeds.2018.07.0350022-3476https://hdl.handle.net/1805/22295Objectives To assess the effect of pulmonary hypertension on neonatal intensive care unit mortality and hospital readmission through 1 year of corrected age in a large multicenter cohort of infants with severe bronchopulmonary dysplasia. Study design This was a multicenter, retrospective cohort study of 1677 infants born <32 weeks of gestation with severe bronchopulmonary dysplasia enrolled in the Children's Hospital Neonatal Consortium with records linked to the Pediatric Health Information System. Results Pulmonary hypertension occurred in 370 out of 1677 (22%) infants. During the neonatal admission, pulmonary hypertension was associated with mortality (OR 3.15, 95% CI 2.10-4.73, P < .001), ventilator support at 36 weeks of postmenstrual age (60% vs 40%, P < .001), duration of ventilation (72 IQR 30-124 vs 41 IQR 17-74 days, P < .001), and higher respiratory severity score (3.6 IQR 0.4-7.0 vs 0.8 IQR 0.3-3.3, P < .001). At discharge, pulmonary hypertension was associated with tracheostomy (27% vs 9%, P < .001), supplemental oxygen use (84% vs 61%, P < .001), and tube feeds (80% vs 46%, P < .001). Through 1 year of corrected age, pulmonary hypertension was associated with increased frequency of readmission (incidence rate ratio [IRR] = 1.38, 95% CI 1.18-1.63, P < .001). Conclusions Infants with severe bronchopulmonary dysplasia-associated pulmonary hypertension have increased morbidity and mortality through 1 year of corrected age. This highlights the need for improved diagnostic practices and prospective studies evaluating treatments for this high-risk population.en-USPublisher PolicyBronchopulmonary dysplasiaPulmonary hypertensionOutcomesEpidemiologyArticle